Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

[F-18]Flornaptitril

Generic Name: [F-18]Flornaptitril

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease

Phase 3

Not yet recruiting

Posted: 2024/02/12

Sponsor:CereMark Pharma, LLC

ID:NCT06254469

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

Brain Hemorrhage Treatment Market Expected to Grow Significantly by 2032 as AI Solutions Gain FDA Approval

2 months ago

The brain hemorrhage treatment market is projected to experience substantial growth through 2032, driven by an aging population and increasing prevalence of risk factors such as hypertension and traumatic brain injuries.

Advancements in Traumatic Brain Injury Clinical Trials Highlighted for 2024

6 months ago

The latest report on Traumatic Brain Injury (TBI) clinical trials for 2024 showcases significant progress in developing novel therapies, with key companies and emerging drugs poised to impact the TBI market. The report emphasizes the importance of ongoing research and the potential of innovative treatments to improve patient outcomes.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy